Over 15 CD39-Targeted Treatments In Clinical Trials, Market Opportunity Surges By 2025
CD39-Targeted Therapies Near Key Milestones, First Approval Projected by 2029Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The CD39 Targeted T ...